Calabresi’s “Cancer at a Crossroads” report was the first step toward historic doubling of the NIH budget Fox Chase’s Winn contemplates Crossroads 2.0

Trump weighs—and abandons—an executive order that would give OMB veto power over NIH grants

The White House last week considered, but ultimately abandoned, a plan to create a panel that would review NIH grants in an effort to weed out projects the administration regards as “woke.”

HHS issues direct final rule to reduce reliance on animal testing

FDA has issued a direct final rule that changes the language in its regulations so that “animal testing” is no longer described as the default or defining form of “nonclinical” safety testing.

September 25, 2026

Vol.52 No.35

By Claire Marie Porter

In Brief

UCLA researchers receive $7M NIH grant to launch trial for immunotherapy-related diabetes

UCLA researchers have received a grant worth up to $7 million over five years from the National Institute of Allergy and Infectious Diseases to launch a first-in-human clinical trial evaluating whether drugs already used to treat autoimmune diseases can prevent or reverse immune checkpoint inhibitor-induced type 1 diabetes, a rare but often permanent complication of cancer immunotherapy.

September 18, 2026

Vol.52 No.34

In Brief

VCU Massey researchers receive $2.5M NIH grant for targeted therapy for breast, pancreatic cancer

Researchers at VCU Massey Comprehensive Cancer Center were recently awarded a $2.5 million R01 grant from NCI. The five-year grant will allow Massey to evaluate the efficacy of TROP2 targeted antibody-drug conjugates to further enhance therapeutic benefits in both breast and pancreatic cancer care.

September 18, 2026

Vol.52 No.34

Clinical Roundup

Cancer biosimilars associated with lower costs for insurers and patients, UCLA study finds

Biologic drugs play an important role in treating cancers such as breast cancer and lymphoma, but their high costs can add to the financial burden of cancer care. Now, lower-cost versions known as biosimilars are gaining ground, and a study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center suggests their growing use is associated with lower costs for both insurers and patients.

September 18, 2026

Vol.52 No.34

Book Review Guest Editorial

From the desk of Kimryn Rathmell: What to read before these beautiful days slip away
My summer reading challenged me to see people, purpose, and complexity in a new way

One of the great pleasures of summer is having more time to read.

August 14, 2026

Vol.52 No.32

By W. Kimryn Rathmell

Calabresi’s “Cancer at a Crossroads” report was the first step toward historic doubling of the NIH budget

Fox Chase’s Winn contemplates Crossroads 2.0

YOU MAY BE INTERESTED IN

Trump weighs—and abandons—an executive order that would give OMB veto power over NIH grants

HHS issues direct final rule to reduce reliance on animal testing

UCLA researchers receive $7M NIH grant to launch trial for immunotherapy-related diabetes

VCU Massey researchers receive $2.5M NIH grant for targeted therapy for breast, pancreatic cancer

Cancer biosimilars associated with lower costs for insurers and patients, UCLA study finds

From the desk of Kimryn Rathmell: What to read before these beautiful days slip away
My summer reading challenged me to see people, purpose, and complexity in a new way

Renew today!

Subscriber content

Never miss an issue!

Login

Calabresi’s “Cancer at a Crossroads” report was the first step toward historic doubling of the NIH budget

Fox Chase’s Winn contemplates Crossroads 2.0

YOU MAY BE INTERESTED IN

Trump weighs—and abandons—an executive order that would give OMB veto power over NIH grants

HHS issues direct final rule to reduce reliance on animal testing

UCLA researchers receive $7M NIH grant to launch trial for immunotherapy-related diabetes

VCU Massey researchers receive $2.5M NIH grant for targeted therapy for breast, pancreatic cancer

Cancer biosimilars associated with lower costs for insurers and patients, UCLA study finds

From the desk of Kimryn Rathmell: What to read before these beautiful days slip awayMy summer reading challenged me to see people, purpose, and complexity in a new way

Never miss an issue!

Login

From the desk of Kimryn Rathmell: What to read before these beautiful days slip away
My summer reading challenged me to see people, purpose, and complexity in a new way